LATEST ALERTS
CBD drug manufacturer GW Pharmaceuticals saw a significant net loss in the last quarter, despite growth and sales of its cannabis-derived pharmaceutical drugs going to plan
Hemp plants in Italy used for the production of CBD are being grown in buildings heated with biofuel
A Swiss CBD company claims to have become the first cannabidiol firm to use liposomes to deliver the substance into users’ bodies and says its new products will deliver CBD to a user’s system four times faster than others
A British biopharmaceutical company will be trialling the use of CBD and other hemp-based products for treating opioid addiction, as well as other conditions
While CBD has been one of THE stories of 2018, the novelty phase is now over, and 2019 will be the year the longer-term future of CBD products becomes clearer. CBD-Intel looks at prospects for the months ahead
Companies which make beverages containing CBD are resorting to new technologies to get around a thorny problem.
CBD is not water soluble, meaning a fatty emulsion needs to be created in order to get the substance to mix with a liquid – but canny companies are using a process called nanemulsion, where the molecule sizes are reduced to enable the CBD to mix better with the drink.
Among a wave of drinkable CBD products released in the UK this year, one of the more controversial is Love Hemp’s CBD-infused bottled water – advertised as being spring water “infused with CBD hemp droplets”
Two Canadian companies with interests in CBD have announced investments in major Italian legal cannabis producers
The CBD-based epilepsy drug Epidiolex could become available in Europe, manufactured from cannabis already growing in eastern England
A Big Tobacco company which invested in a medical cannabis startup will not influence how the smaller firm is run, according to bosses at Oxford Cannabinoid Technologies
Two North American companies have announced collaborations with established drug delivery firms to produce and expand distribution for oral CBD strips – soluble strips that dissolve in the mouth
Many cannabis strains marketed as distinct are in fact chemically much the same, but there may also be non-obvious differences and their effects on humans should not be judged purely on THC and CBD content, scientists say
Canadian company Emerald Health Therapeutics is set to sign a deal to use an extraction facility capable of processing 1000 tonnes of biomass to produce 600m softgel CBD capsules a year
Intrexon, an American biotech company listed on the Nasdaq stock exchange, has announced a development in its microbial platform capable of producing cannabinoids for medical use
Rare cannabinoids that cannot practically be extracted from hemp will instead be manufactured by specially-created micro-organisms in a partnership between a Canadian and a US company
The town of Nelas in north central Portugal is to be the site of a new CBD oil factory producing medicinal products extracted from cannabis sativa for export to America and within Europe
Vaping businesses in the US are experiencing a shift in consumer preferences for methods of extracting CBD and THC from cannabis, with more manufacturers developing distillers to help meet the growing demand for purer products
Enovap, an innovative French hardware manufacturer, has announced plans to move into the US market, where it hopes to apply its technology to medicinal cannabis use
E-cigarette firms who already have devices on the market are manoeuvring to see how their products can serve the growing marijuana industry – and they face competition there from some well-financed start-ups.
39 U.S. states and the District of Columbia have laws that legalise and/or decriminalise marijuana use or possession to various extents. E-cig companies are well positioned to enter the emerging marijuana market because of their technical expertise and intimate knowledge of the science behind vaporisers, and several types of cannabis-compatible vaporisers, or “c-cigs”, may succeed in the U.S. market.
Stay up-to-date with key market trends and regulatory news and receive complimentary data on a regular basis.
"*" indicates required fields
Sign up to access our business and regulatory briefings and get the most updated news, insights and our expert analysis to keep you on top of worldwide industry trends.
